# FDA Inspection 1164646 - Janusz Tomaszewski - February 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/janusz-tomaszewski/1bcedd28-75db-4ce8-adf2-59f33288b911
Source feed: FDA_Inspections

> FDA Inspection 1164646 for Janusz Tomaszewski on February 25, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164646
- Company Name: Janusz Tomaszewski
- Inspection Date: 2022-02-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258475 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/janusz-tomaszewski/7fb08456-4b12-4a6e-ae68-7240057093ec)
- [FDA Inspection 1258475 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/janusz-tomaszewski/dedd3090-f906-459b-9144-fc077f0576fc)

Company: https://www.keypedia.com/companies/janusz-tomaszewski/f08c455b-65ec-4667-8dfa-a1f4ff12f013

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c